Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harris, J. R.
Right arrow Articles by Hellman, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, J. R.
Right arrow Articles by Hellman, S.
Related Articles
Right arrowRelated Article

Journal of Clinical Oncology, Vol 1, 184-189, Copyright © 1983 by American Society of Clinical Oncology


ARTICLES

Clinical-pathologic study of early breast cancer treated by primary radiation therapy

JR Harris, JL Connolly, SJ Schnitt, RB Cohen and S Hellman

We performed a clinical-pathologic review of 231 patients with early breast cancer treated by primary radiation therapy. There were 27 patients with infiltrating ductal carcinoma treated with excisional biopsy whose tumors showed a constellation of histologic features: moderate or marked intraductal carcinoma in the tumor, intraductal carcinoma in the adjacent tissue, and high nuclear grade. These patients had a 5-yr local tumor control rate of 61% compared to 96% for similar patients whose tumors did not show all three features. Radiation dose to the primary tumor area influenced the likelihood of local recurrence in these 27 patients: 15 of these patients received 6000 rads or more to the primary tumor area and had a 5-yr local tumor control rate of 84%, compared to 48% for the 12 patients who received less than 6000 rads. These results indicate that a subgroup of breast cancer patients can be identified that has a high risk of local recurrence when an insufficient radiation dose (i.e., less than 6000 rads) is delivered to the primary tumor area.

Related Article

  • Evolution of Breast-Conserving Therapy for Localized Breast Cancer
    Stuart J. Schnitt and Jay R. Harris
    JCO 2008 26: 1395-1396 [Full Text]


This article has been cited by other articles:


Home page
JCOHome page
S. J. Schnitt and J. R. Harris
Evolution of Breast-Conserving Therapy for Localized Breast Cancer
J. Clin. Oncol., March 20, 2008; 26(9): 1395 - 1396.
[Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
T. Ishida, A. Furuta, T. Moriya, and N. Ohuchi
Pathological Assessment of Intraductal Spread of Carcinoma in Relation to Surgical Margin State in Breast-conserving Surgery
Jpn. J. Clin. Oncol., April 1, 2003; 33(4): 161 - 166.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1983 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online